— Know what they know.
Not Investment Advice

IBIO NASDAQ

iBio, Inc.
1W: -5.0% 1M: -13.7% 3M: -30.2% YTD: -44.1% 1Y: +37.2% 3Y: -80.5% 5Y: -99.8%
$1.12
+0.01 (+1.35%)
 
Weekly Expected Move ±6.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 31 · $72.3M mcap · 56M float · 1.41% daily turnover · Short 60% of daily vol

📊 Key Metrics

TTM
$0M
Revenue
-75.0% YoY
$-33M
Net Income
-79.8% YoY
$-24M
Free Cash Flow
-55.3% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-65.7%
ROA-54.0%
ROIC21688.6%

Valuation

P/E-3.5
P/B1.4
EV/EBITDA-3.0

Leverage

Debt/Equity0.03
Current Ratio7.85
Interest Cov.-622.5x

Quality Scores

Piotroski F4/9
Altman Z2.87
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms